Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
2005; BMJ; Volume: 91; Issue: 6 Linguagem: Inglês
10.1136/hrt.2004.057190
ISSN1468-201X
Autores Tópico(s)Inflammasome and immune disorders
ResumoAbstract A substantial body of evidence has accumulated to suggest a role for the xanthine oxidase metabolic pathway in the pathophysiology of chronic heart failure and other cardiovascular diseases BNP, brain natriuretic peptideCHF, chronic heart failureNO, nitric oxideXO, xanthine oxidaseallopurinolheart failurexanthine oxidoreductase
Referência(s)